Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen? (Q28196511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Li Wei

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

Basic and Clinical Pharmacology and Toxicology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

275-280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

A randomized trial of aspirin to prevent colorectal adenomas

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs: is it time to believe the hype?

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Nonsteroidal antiinflammatory drugs after acute myocardial infarction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Clinical practice. Aspirin for primary prevention of coronary events

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Effect of ibuprofen on cardioprotective effect of aspirin

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

The lady aspirin for cardiovascular disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1742-7843.2006.PTO_371.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Association between naproxen use and protection against acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

The mechanism of action of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2006.PTO_371.X

10.1111/J.1742-7843.2006.PTO_371.X

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3337663

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16611202%20AND%20SRC:MED&resulttype=core&format=json

release_edrqznbtdffppdil7enhkd5bw4

19 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/edrqznbtdffppdil7enhkd5bw4

mapped directly with Wikidata item

24 November 2022

based on heuristic

3337663

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3337663